Senti Biosciences Holdings
SNTI
42 hedge funds and large institutions have $175M invested in Senti Biosciences Holdings in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 8 closing their positions.
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
8% more funds holding
Funds holding: 39 → 42 (+3)
1.34% less ownership
Funds ownership: 8.85% → 7.5% (-1.3%)
16% less capital invested
Capital invested by funds: $209M → $175M (-$33.1M)
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sculptor Capital
New York
|
+$13.5M |
| 2 |
JP Morgan Chase
New York
|
+$13.2M |
| 3 |
CIM
Cowen Investment Management
New York
|
+$4.98M |
| 4 |
TCA
Taconic Capital Advisors
New York
|
+$4.98M |
| 5 |
CAC
Cowen and Company
New York
|
+$2.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$28.9M |
| 2 |
DCP
D1 Capital Partners
New York
|
-$19.4M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$19.1M |
| 4 |
PVI
Pura Vida Investments
New York
|
-$2.54M |
| 5 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
-$1.99M |
SNTI Hedge Fund Activity: Q4 2021 in Review
42 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Senti Biosciences Holdings (SNTI) for Q4 2021, worth a combined $175M — down 16% from $209M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new SNTI positions and 8 closed out — a net gain of 3 holders — while 5 added to existing stakes and 9 trimmed.
The largest buyer was Sculptor Capital, adding an estimated $13.5M. The largest seller was T. Rowe Price Associates, cutting an estimated $28.9M.
- 42 institutional investors held Senti Biosciences Holdings (SNTI) as of Q4 2021, up from 39 in Q3 2021.
- Funds reported $175M of Senti Biosciences Holdings stock for Q4 2021, down 16% quarter-over-quarter.
- 11 funds opened new Senti Biosciences Holdings positions in Q4 2021 and 8 closed out, a net change of +3 holders.
- The largest Senti Biosciences Holdings buyer in Q4 2021 was Sculptor Capital, an estimated $13.5M added.
- The largest Senti Biosciences Holdings seller in Q4 2021 was T. Rowe Price Associates, an estimated $28.9M sold.
Based on aggregated 13F filings for Q4 2021.